Partnerships Critical To Building China’s R&D Ecosystem (Pt.1)
This article was originally published in PharmAsia News
Executive Summary
China has outlined the main goals for its 13th Five-Year Plan, under which the pharmaceutical sector is seen moving in the direction of increased innovation, and the government seems set to bring biologic medicine development to a new strategic level. But building a healthy ecosystem for drug development will require strong collaboration between multinational pharmaceutical companies and their domestic peers, MNCs told a recent forum in Shanghai.